Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations 
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
Japan Earthquake Disrupts Auto and Chip Supply Chains 
World game at war: why some European nations have threatened a World Cup boycott 
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth 
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest 
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit 
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook 
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9% 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook 
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation 
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 
BETHLEHEM, Pa., May 03, 2018 -- B. Braun Medical Inc., an industry pioneer in offering products not made with DEHP and PVC, will showcase its portfolio of solution containers at the CleanMed 2018 Conference & Exposition on May 7-9 at the Sheraton San Diego Hotel and Marina in booth #203.
Di-ethylhexyl Phthalate (DEHP) and Polyvinyl Chloride (PVC) are potentially toxic to patients and the environment – and they’re commonly used in IV bags, tubing, and packaging.
“B. Braun has been at the forefront of recognizing the patient and environmental risk posed by exposure to products containing DEHP and PVC. We were one of the first IV fluid manufacturers to remove these toxic substances from many of our products and proudly remain the only supplier that offers a full-line of IV solution containers that are not made with DEHP and PVC,” said Tom Sutton, Vice President of Marketing, Medical Device and Pharmaceutical Systems.
Over the past seven years, B. Braun has invested more than $750 million in developing increased capacity, and innovative ways to offer environmentally friendly IV solutions. This includes new product lines not made with DEHP, PVC, or natural rubber latex. B. Braun actively supports policies calling for the industry-wide reduction of these chemicals and natural rubber latex in medical devices.
For more information on these products, call B. Braun Clinical and Technical Support at 800-854-6851. For more information on DEHP and PVC in healthcare, visit www.BBraunCares.com.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. Other key product areas include ostomy and wound care, dialysis, nutrition, pharmacy admixture and compounding. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 61,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Contact: Jason Ford
B. Braun Medical Inc.
610.997.4722
[email protected]
